A pilot study of treatment of active ulcerative colitis with natalizumab, a humanized monoclonal antibody to alpha-4 integrin.

F H Gordon; M I Hamilton; S Donoghue; C Greenlees; T Palmer; D Rowley-Jones; A P Dhillon; P L Amlot; R E Pounder

doi:10.1046/j.1365-2036.2002.01205.x

A pilot study of treatment of active ulcerative colitis with natalizumab, a humanized monoclonal antibody to alpha-4 integrin.

Identifier:nobleid.org/w1/20260515/65FF7B3C

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/65FF7B3C.svg?ark=w1%2F20260515%2F65FF7B3C)](https://nobleid.org/work/w1/20260515/65FF7B3C)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

A pilot study of treatment of active ulcerative colitis with natalizumab, a humanized monoclonal antibody to alpha-4 integrin.

Identifier:nobleid.org/w1/20260515/65FF7B3C

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/65FF7B3C.svg?ark=w1%2F20260515%2F65FF7B3C)](https://nobleid.org/work/w1/20260515/65FF7B3C)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work